BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Company Overview - The company is a multi-platform oncology firm with over 20 ongoing clinical Phase II and Phase III trials [3] Innovation Approach - The presentation aims to discuss the company's unique approach to innovation, including the scientific and medical concepts and their execution [2]